Anti-Ebola treatment being trialled for Covid-19 patients

17 April 2020

Remdesivir, an anti-Ebola treatment, is being developed and trialled in a study led by Professor Sarah Pett and Professor Abdel Babiker (both MRC Clinical Trials Unit at UCL) in patients with Covid-19.